Epsilon Reaches Key Milestone: ETS Now Integrates with PAS Accounting Out-of-the-Box
NEW YORK, NY, UNITED STATES, May 29, 2025 / EINPresswire.com / -- Epsilon, a leader in capital markets technology solutions, today announced a major milestone in the evolution of ETS, its innovative trade management platform. With the release of version 5.1, ETS now includes out-of-the-box integration of the Principia Analytic System (PAS) subledger libraries as part of its suite of integrated components.
This enhancement marks a significant step forward in ETS's ability to deliver full front-to-back support for fixed income and derivative products. Leveraging the proven flexibility and performance of PAS libraries, the integration substantially shortens implementation timelines and enhances interoperability.
'Seamless integration of PAS subledger libraries is a pivotal moment for us and our clients,' said Debashis Sen, CEO of Epsilon. 'ETS can now support our clients across the entire lifecycle—from trade qualification to trade management to trade accounting—all on a state-of-the-art technology stack designed to reduce implementation time and support costs.'
The release underscores Epsilon's commitment to helping financial institutions manage everything on their balance sheet through streamlined, cross-platform solutions.
About Epsilon Technologies Group
Epsilon is a vibrant capital markets technology solutions and services firm serving small and medium-sized financial institutions such as regional banks, GSEs, and Federal Home Loan Banks. The Group's deep expertise embraces every aspect of software development, products, data, technologies, and consulting. Epsilon offers ETS, Principia Analytic System, and pasVal as licensed products, and various innovative, bespoke solutions across a broad set of capital markets domains. Epsilon also offers a full range of independent consulting services, including implementation, advisory, analytics, risk management, accounting, and data modeling.
To learn more about Epsilon, ETS, Principia Analytic System and pasVal, visit www.epsilontg.com.
Douglas Long
Epsilon Technologies Group
+1 212-480-2270
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
4 days ago
- Associated Press
Epsilon Reaches Key Milestone: ETS Now Integrates with PAS Accounting Out-of-the-Box
NEW YORK, NY, UNITED STATES, May 29, 2025 / / -- Epsilon, a leader in capital markets technology solutions, today announced a major milestone in the evolution of ETS, its innovative trade management platform. With the release of version 5.1, ETS now includes out-of-the-box integration of the Principia Analytic System (PAS) subledger libraries as part of its suite of integrated components. This enhancement marks a significant step forward in ETS's ability to deliver full front-to-back support for fixed income and derivative products. Leveraging the proven flexibility and performance of PAS libraries, the integration substantially shortens implementation timelines and enhances interoperability. 'Seamless integration of PAS subledger libraries is a pivotal moment for us and our clients,' said Debashis Sen, CEO of Epsilon. 'ETS can now support our clients across the entire lifecycle—from trade qualification to trade management to trade accounting—all on a state-of-the-art technology stack designed to reduce implementation time and support costs.' The release underscores Epsilon's commitment to helping financial institutions manage everything on their balance sheet through streamlined, cross-platform solutions. About Epsilon Technologies Group Epsilon is a vibrant capital markets technology solutions and services firm serving small and medium-sized financial institutions such as regional banks, GSEs, and Federal Home Loan Banks. The Group's deep expertise embraces every aspect of software development, products, data, technologies, and consulting. Epsilon offers ETS, Principia Analytic System, and pasVal as licensed products, and various innovative, bespoke solutions across a broad set of capital markets domains. Epsilon also offers a full range of independent consulting services, including implementation, advisory, analytics, risk management, accounting, and data modeling. To learn more about Epsilon, ETS, Principia Analytic System and pasVal, visit Douglas Long Epsilon Technologies Group +1 212-480-2270 email us here Visit us on social media: LinkedIn Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
6 days ago
- Yahoo
Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?
NeuroPace, Inc. (NASDAQ:NPCE) released preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for drug-resistant idiopathic generalized epilepsy (IGE). The study met its primary 12-week post-implant safety endpoint, demonstrating a low rate of serious adverse events related to the device and implant procedure. The study did not reach statistical significance for the primary effectiveness endpoint in the overall study population, which was to show a longer time to a second generalized tonic-clonic seizure in the active stimulation group compared to the sham stimulation the data did show a clinically meaningful and statistically significant response in the primary effectiveness endpoint within a subgroup of patients with lower baseline frequency of generalized tonic-clonic seizures, representing most trial participants. Additionally, the company said that within the entire trial population, clinically relevant data, including median percent seizure reduction, responder rates, and improvement in seizure-free days, showed numerically robust and clinically meaningful improvements over the first year of treatment and continued in those who have progressed to the second year. The company will engage with the FDA to discuss regulatory pathways based on the data. These discussions may include the possibility of utilizing the overall median seizure reduction data across the full study population and pursuing a more targeted indication focused on patients with lower baseline seizure frequency who may represent a majority of IGE patients. In April, NeuroPaces terminated its distribution relationship for SEEG products and will begin winding down the relationship in the fourth quarter of 2025 and continuing through the first quarter of 2026. NeuroPace announced three-year effectiveness data from the Post-Approval Study (PAS) of the RNS System in April. The data showed an 82% median reduction in seizures in adults treated with brain-responsive stimulation for drug-resistant focal epilepsy and seizure freedom, with 42% of patients remaining seizure-free for 6+ months. Sales grew 24% to $22.5 million in the first quarter of 2025. RNS System revenue grew 29%, excluding revenue from implants in the NAUTILUS study in the first quarter of 2024. Increased sales of the RNS System primarily drove the company's revenue growth. The company also continued to generate meaningful revenue from sales of SEEG products. NeuroPace raised the fiscal year 2025 sales guidance from $92 million-$96 million to $93 million-$97 million compared to the consensus of $93.64 million. Price Action: NPCE stock is down 33.90% at $11.68 at the last check Tuesday. Read Next:Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data? originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
23-05-2025
- Yahoo
Epsilon Energy (EPSN) was Among the Energy Stocks That Gained the Most This Week
The share price of Epsilon Energy Ltd. (NASDAQ:EPSN) surged by 4.55% between May 14 and May 21, 2025, putting it among the Energy Stocks that Gained the Most This Week. Let's shed some light on the development. A pipeline of natural gas cutting through a rural landscape. Epsilon Energy Ltd. (NASDAQ:EPSN) is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The share price of Epsilon Energy Ltd. (NASDAQ:EPSN) surged after the company reported strong results for its Q1 2025 last week, posting an adjusted EPS of $0.22 against estimates of $0.14. The energy firm's revenue also grew by a massive 102% YoY to $16.16 million, beating expectations by $4.45 million. Moreover, Epsilon's Marcellus business performed very well during the quarter, with all delayed turn-in-line wells now on production and the lifting of the curtailments it sustained for most of last year. As a result, the company's total production rose by 43% compared to the previous quarter, with a noticeable surge in its gas output. EPSN revealed that its Marcellus upstream cash flows were up sequentially by over 200% due to a 58% increase in production and a 70% increase in realized pricing, significantly contributing to its strong performance during the quarter. While we acknowledge the potential of EPSN to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than EPSN but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 10 Cheap Energy Stocks to Buy Now and 10 Most Undervalued Energy Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio
